KMID : 1104820190070010022
|
|
Journal of Digestive Cancer Research 2019 Volume.7 No. 1 p.22 ~ p.25
|
|
Extraordinary Response of Metastatic Pancreatic Cancer to Chemotherapy
|
|
Shin Dong-Woo
Kim Jin-Kook Lee Jong-Chan Kim Jai-Hwan Hwang Jin-Hyeok
|
|
Abstract
|
|
|
A 58-year-old woman presented with right flank and back pain for one month. After undergoing an abdominal computed tomography (CT), she was referred to our hospital. The abdominal CT showed a hypodense pancreatic tail mass with multiple retroperitoneal lymph node metastases. Positron emission tomography-computed tomography (PET-CT) scan showed high 18F-FDG uptake in pancreatic tumor and enlarged lymph nodes. Endoscopic ultrasound fine needle aspiration (EUS-FNA) revealed adenocarcinoma, which stained strongly in hENT1 (human equilibrative nucleoside transporter 1) on immunohistochemistry. She received gemcitabine 1,000 mg/m2 + nanoparticle albumin-bound paclitaxel 125 mg/m2 as a palliative chemotherapy. Follow-up abdominal CT and PET-CT after 4 cycles of chemotherapy showed that both pancreatic mass and the metastatic retroperitoneal lymph nodes were nearly disappeared. We report a case of 58-year-old female with metastatic pancreatic cancer who had a dramatic response to palliative chemotherapy (gemcitabine plus nanoparticle albumin-bound paclitaxel).
|
|
KEYWORD
|
|
Metastatic pancreatic cancer, Gemcitabine, Nanoparticle albumin-bound paclitaxel, hENT1 immunohistochemical stain
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|